Acquisition Context EuTech Scientific Services was acquired by Tentamus Group in January 2021, signaling a larger platform and potential cross-sell opportunities within a global network of contract research and testing services.

Niche Focus Specializes in developing and optimizing analytical methods for pharmaceutical, medical device, and nutraceutical sectors, presenting sales opportunities to clients needing method development, validation, or method transfer services.

Proven Track Record Longstanding experience since 1994 with a demonstrated revenue range indicating a steady demand for contract research services, which can be leveraged to position Tentamus network capabilities to prospective customers.

Technology Backbone Tech stack includes web-based data and analytics platforms (WordPress, MySQL, Google Cloud, PHP, jQuery), suggesting potential for scalable digital offerings, client portals, and data management services to streamline CRO projects.

Market Positioning Compared to large CROs, EuTech occupies a mid-market niche with modest employee size and mid-range revenue, presenting opportunities to target mid-sized pharmaceutical, device, and nutraceutical firms seeking flexible, cost-effective analytical services within the Tentamus ecosystem.